0000905148-16-001816.txt : 20160809 0000905148-16-001816.hdr.sgml : 20160809 20160809172520 ACCESSION NUMBER: 0000905148-16-001816 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160601 FILED AS OF DATE: 20160809 DATE AS OF CHANGE: 20160809 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REATA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001358762 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113651945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2801 GATEWAY DRIVE SUITE 150 CITY: IRVING STATE: TX ZIP: 75063 BUSINESS PHONE: 972-865-2206 MAIL ADDRESS: STREET 1: 2801 GATEWAY DRIVE SUITE 150 CITY: IRVING STATE: TX ZIP: 75063 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Traweek James W JR CENTRAL INDEX KEY: 0001665299 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37785 FILM NUMBER: 161819302 MAIL ADDRESS: STREET 1: 2000 MCKINNEY AVE STREET 2: SUITE 2125 CITY: DALLAS STATE: TX ZIP: 75201 4/A 1 form4.xml X0306 4/A 2016-06-01 2016-06-01 0001358762 REATA PHARMACEUTICALS INC RETA 0001665299 Traweek James W JR C/O CPMG, INC. 2000 MCKINNEY AVE., SUITE 2125 DALLAS TX 75201 true Class A common stock 2016-06-01 4 P 0 802000 11 A 912969 I See footnote These shares of Class A common stock ("Shares") were inadvertently omitted from the Reporting Person's Form 4 filed June 1, 2016, and subsequent Forms 4. These Shares were purchased in the Issuer's initial public offering, which closed on June 1, 2016. These Shares are held in various funds for which CPMG, Inc. serves as investment manager. The Reporting Person is a co-director and co-shareholder of CPMG, Inc. The Reporting Person disclaims beneficial ownership of the Shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. /s/ James W. Traweek, Jr. 2016-08-09